PON2 antibody [N1C2], 1 mg/ml (100 ul)
Loading...
Loading...
Loading...
Loading...
Product Description
Specifications
| Size | 100 µL |
| Estimated Lead Time | 1-2 weeks |
| Species | Human, Mouse |
| Host Species | Rabbit |
| Gene Id | 5445 |
| Protein Name / Synonyms | PON2 |
| Concentration (lot specific) | 1 mg/ml |
| Recommended Applications | IHC (Formalin-fixed paraffin-embedded sections), Western blot |
| Shipping Type | Blue ice |
| Storage | -20°C |
Synonyms
PON2 antibody, paraoxonase nirs antibody, PON 2 antibody, aromatic esterase 2 antibody, A-esterase 2 antibody, serum aryldialkylphosphatase 2 antibody, serum paraoxonase/arylesterase 2 antibody, paraoxonase 2 antibody
Specificity
Species Reactivity
Human, Mouse
Format
Product Type
Primary antibody
Formulation
0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Calculated Molecular Weight
39 kDa
Immunogen
Recombinant fragment corresponding to a region within amino acids 1 and 295 of PON2 (Uniprot ID# Q15165)
Applications
Applications Tested
IHC (Formalin-fixed paraffin-embedded sections),Western blot
Application Notes
Suggested starting dilutions are as follows: WB: 1:500-1:3000, IHC-P: 1:100-1:1000 [suggested antigen retrieval using heat mediated 10mM Citrate buffer (pH6.0) or Tris-EDTA buffer (pH8.0)]. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.
Sample (50 ug of whole cell lysate)
A: mouse liver
10% SDS PAGE
107-10426 diluted at 1:1000
A: mouse liver
10% SDS PAGE
107-10426 diluted at 1:1000
Immunohistochemical analysis of paraffin-embedded N87 xenograft, using PON2(107-10426) antibody at 1:100 dilution.
Sample (30 ug of whole cell lysate)
A: A431
10% SDS PAGE
PON2 antibody
107-10426 diluted at 1:1000
A: A431
10% SDS PAGE
PON2 antibody
107-10426 diluted at 1:1000
Storage
Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
Expiration:
12 months from the date of shipment when stored properly.
